Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ScRNAseq of mock, HSV-1 or HSV-2 infected C57BL/6 Vaginal tissue at 5 days post infection

ABSTRACT: scRNAseq of mock, HSV-1 or HSV-2 infected C57BL/6 Vaginal tissue at 5 days post infection

PROVIDER: PRJNA677918 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

scRNAseq of mock, HSV-1 or HSV-2 infected C57BL/6 Vaginal tissue at 5 days post infection

Project description:Purpose: To compare single cell transcriptional profiling (scRNAseq) of different murine genital herpes infection models with HSV1-McKrae and HSV2-186. Method: DMPA-treated WT C57BL/6 mice were infected with HSV1-McKrae, HSV2-186 or PBS intravaginally. Vaginal tissues were harvested at 5 days post infection, live cells were sorted, a minimum of 16,000 cells were used for scRNAseq. Results: By tSNE visualization of 21,633 cells across all samples, 17 distinct clusters were resolved. We found significantly increased levels of Interferons-Stimulated-Genes (ISGs) in the neutrophils potentially contributing to disease onset and progression in HSV2 genital infections. Conclusion: Our study is the first comparison between the transcriptional signature of two genital herpes model- namely HSV1 and HSV2. Generated by scRNAseq, this study would provide researchers with gene candidates associated with the disease progression and inflammation induced by genital infections with HSV1 and HSV2.

2020-12-31 | GSE161336 | GEO

scRNASeq of HSV-1 latency

Project description:scRNASeq of HSV-1 latency

| PRJEB39022 | ENA

RNA polymerase II ChIP-seq in HSV-1 and mock infected cells

Project description:The goal of this study was to determine how RNA poymerase II (Pol II) occupancy changed in response to herpes simplex virus-1 (HSV-1) infection using ChIP-seq of Pol II. ChIP assays were performed 4 hours after cells were infected (or mock infected) with HSV-1. Because host cell Pol II transcribes the HSV-1 genome, the ChIP-seq data also reveal polymerase occupancy on the viral genome.

2015-12-30 | GSE66487 | GEO

Endogenous retroviruses mediate IFN-independent protection against HSV-2 infection

Project description:Endogenous retroviruses (ERVs) are genomic sequences that originated from retroviruses and are present in most eukaryotic genomes. Both beneficial and detrimental functions are attributed to ERVs, but whether ERVs contribute to antiviral immunity is not well studied. Here, we used herpes simplex virus type 2 (HSV-2) infection as a model and found that mice deficient in Toll-like receptor 7 (Tlr7-/-) that have high systemic levels of infectious ERVs are resistant to intravaginal HSV-2 infection, compared with wildtype C57BL/6 (B6) mice. We deleted the endogenous ecotropic murine leukemia virus (Emv2) locus on the Tlr7-/- background (Emv2-/-Tlr7-/-) and found that Emv2-/-Tlr7-/- mice lose protection against HSV-2 infection. Intravaginal application of purified ERVs prior to HSV-2 infection delays disease in both B6 and highly susceptible interferon-alpha receptor-deficient (Ifnar1-/-) mice. We did not observe enhanced type I interferon (IFN-I) signaling in the vaginal tissues from Tlr7-/- mice or B6 mice treated with purified ERVs, and instead found enrichment in genes associated with extracellular matrix organization. Together, our results revealed an IFN-independent modulation of the vaginal epithelium by ERVs that protects mice against vaginal HSV-2 infection and delays disease.

2021-10-06 | GSE185281 | GEO

Effect of NK1.1+ cell depletion on vaginal neutrophil gene expression during HSV-1 infection

Project description:Depletion of NK1.1+ cells from mice prior to intravaginal HSV-1 infection results in severely increased genital disease and mucosal tissue damage. We determined that this loss of host protection in the absence of NK1.1+ cells was dependent on neutrophils, suggesting that NK1.1+ cells may be modulating neutrophil behavior during infection. To obtain an unbiased view of the transcriptional changes occuring in neutrophils that might explain this difference in disease outcomes, we performed sequencing of total RNA from neutrophils isolated from vaginas of intact or NK1.1 depleted mice 5 days after HSV-1 infection.

2022-04-30 | GSE201713 | GEO

PMs were infected with HSV-1 or not

Project description:Transcriptome profiling analysis to study deubiquitinase gene expression levels in mock and HSV-1 infected PMs

2024-06-01 | GSE233794 | GEO

Transcription profiling of human foreskin fibroblast B virus and HSV-1 infected cells

Project description:The overall cellular gene expression patterns engaged as a result of B virus (E2490) and HSV-1 (MacIntyre) infection at 1h, 3h, and 5h post infection were analyzed. Differentially regulated immune responsive genes during the early infection stage were identified. Experiment Overall Design: The variables tested were infection (Mock, BV, HSV-1) and time (1, 3, 5h). Samples were performed in biological duplicate.

2009-11-27 | E-GEOD-4521 | biostudies-arrayexpress

RNA polymerase II ChIP-seq in HSV-1 and mock infected cells

Project description:RNA polymerase II ChIP-seq in HSV-1 and mock infected cells

| PRJNA277056 | ENA

Genome-wide small RNAs analysis of herpes simplex virus type 1 (HSV-1) infected cells

Project description:The goal of this study was to compare small RNA profiles (sRNA-seq) of HSV-1 infected and mock infected human fibroblast KMB17 strain at 48 hours post infection.

2017-08-10 | GSE102470 | GEO

Gene expression data from aminoglycoside-treated vaginal tissues.

Project description:C57 Bl/6 mice were treated subcutaneously with Depo-provera. Five days after Depo treatment mice were treated intravaginally with 1mg neomcyin or equivalent volume of saline every day for six days. On the seventh day, mice were scarificed, vaginal tissue harvested and RNA extracted. Matrix normalized data is provided as neomycin expression data normalized against pbs expression data.

2017-02-16 | GSE94909 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data